Among active 13F managers last quarter, 3 opened and 15 added, while 12 reduced; the largest holder to move was Millennium Management LLC (11× the prior stake). Over the last 180 days, 1 insider sold and none bought, a net -$2K in open-market trades.
The legs disagree, or only one of them leans.
72 tracked 13F filers disclose a position in PEPG as of the latest SEC 13F filings, a combined $91.3M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 20.1M | $36.1M | —Held | Q2 2026 | |
| 2 | Commodore Capital LP | 4.5M | $8.1M | —Held | Q2 2026 | |
| 3 | Viking Global Investors LP | 3.5M | $6.3M | —Held | Q2 2026 | |
| 4 | Laurion Capital Management LP | 2.8M | $5.0M | —Held | Q2 2026 | |
| 5 | Vivo Capital, LLC | 2.3M | $4.2M | —Held | Q2 2026 | |
| 6 | Millennium Management LLC | 2.1M | $3.7M | ▲11× Added · +1.9M sh | Q1 2026 | |
| 7 | Vanguard Capital Management LLC | 1.9M | $3.5M | ▼−0.1% Reduced · −2K sh | Q2 2026 | |
| 8 | ADAR1 Capital Management, LLC | 1.6M | $2.8M | ▲44× Added · +1.6M sh | Q1 2026 | |
| 9 | Pictet Asset Management Holding SA | 1.3M | $2.3M | ▼−3.4% Reduced · −46K sh | Q1 2026 | |
| 10 | BlackRock, Inc. | 1.3M | $2.3M | ▲+2.1% Added · +26K sh | Q2 2026 | |
| 11 | Morgan Stanley | 999K | $1.8M | ▼−7.9% Reduced · −85K sh | Q1 2026 | |
| 12 | Qube Research & Technologies Ltd | 706K | $1.3M | ▲23× Added · +675K sh | Q1 2026 | |
| 13 | Citadel Advisors LLC | 658K | $1.2M | ▲+217% Added · +450K sh | Q2 2026 | |
| 14 | AWM Investment Company, Inc. | 600K | $1.1M | ▼−67% Reduced · −1.2M sh | Q2 2026 | |
| 15 | Monimus Capital Management, LP | 588K | $1.1M | ▼−1.8% Reduced · −11K sh | Q2 2026 | |
| 16 | Geode Capital Management, LLC | 523K | $943K | ▼−2.3% Reduced · −13K sh | Q2 2026 | |
| 17 | Creek Drive Management Group LLC | 450K | $810K | —Held | Q2 2026 | |
| 18 | Ikarian Capital, LLC | 447K | $805K | —Held | Q2 2026 | |
| 19 | Susquehanna International Group, LLP | 442K | $783K | ▲+252% Added · +317K sh | Q1 2026 | |
| 20 | Diadema Partners LP | 373K | $672K | ▲+147% Added · +222K sh | Q2 2026 | |
| 21 | Boothbay Fund Management, LLC | 366K | $659K | ▲+4.2% Added · +15K sh | Q2 2026 | |
| 22 | Marshall Wace, LLP | 299K | $528K | ▲+2.7% Added · +8K sh | Q1 2026 | |
| 23 | Boxer Capital Management, LLC | 273K | $491K | —Held | Q2 2026 | |
| 24 | Vanguard Fiduciary Trust Co | 261K | $471K | ▲+0.7% Added · +2K sh | Q2 2026 | |
| 25 | State Street Corp | 229K | $413K | —Held | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership. 2 value rows are withheld because the reported units disagree with same-security peers; share counts are unchanged.
Last quarter, 3 funds opened a new position in PEPG and 15 added to an existing one, while 12 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Revolution Medicines IncRVMD | 30 funds | $766.0M |
| Amazon.com IncAMZN | 29 funds | $20.7B |
| Microsoft CorpMSFT | 29 funds | $18.6B |
| Eli Lilly & CoLLY | 28 funds | $6.5B |
| Visa Inc-Class A SharesV | 27 funds | $5.9B |
| Unitedhealth Group IncUNH | 27 funds | $3.5B |
| Boston Scientific CorpBSX | 27 funds | $2.7B |
| Nvidia CorpNVDA | 26 funds | $32.0B |
| Meta Platforms Inc-Class AMETA | 26 funds | $11.0B |
| Micron Technology IncMU | 26 funds | $7.3B |
| JPMorgan Chase & CoJPM | 26 funds | $6.6B |
| Chevron CorpCVX | 26 funds | $4.4B |
Ranked by how many of PEPG's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in PEPG.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| May 21, 2026 | Kasraian Kasra | Chief Technical Officer | Sell (S) | 1K | $2K |
| Mar 4, 2026 | McArthur James G | President and CEO, Director | Sell (S) 2 lots, same day | 5K | $33K |
| Mar 4, 2026 | Donnelly Noel | Chief Financial Officer | Sell (S) 2 lots, same day | 2K | $13K |
| Mar 4, 2026 | Streck Paul | EVP, Head of R&D | Sell (S) 2 lots, same day | 2K | $12K |
| Sep 30, 2025 | Oxford Science Enterprises plc | Insider | Buy (P) | 200K | $640K |
| Sep 26, 2025 | RA Capital Healthcare Fund LP | Director, 10% Owner | Buy (P) | 9.4M | $30.0M |
| May 30, 2025 | Streck Paul | EVP, Head of R&D | Buy (P) | 8K | $10K |
| Apr 17, 2025 | McArthur James G | President and CEO, Director | Buy (P) | 10K | $14K |
| Apr 8, 2025 | McArthur James G | President and CEO, Director | Buy (P) | 42K | $48K |
| Feb 26, 2025 | Donnelly Noel | Chief Financial Officer | Sell (S) | 2K | $3K |
| Feb 26, 2025 | DeLena Mary Beth | General Counsel | Sell (S) | 1K | $2K |
| Jul 25, 2024 | Mellion Michelle L | Chief Medical Officer | Sell (S) | 8K | $137K |
One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 25 | 23 | – |
Insiders Form 4 open-market | 0 | 1 | -$2K |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for PEPG
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/PEPG/capital-change-brief"
Use Arkolith's capital_change_brief for PEPG. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for PEPG. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.